Ketamine and Treatment-Resistant Depression
Copyright© by the American Association of Nurse Anesthetists..
Major depressive disorder affects tens of millions of people each year. One-third of those affected have depression that is resistant to conventional pharmacologic, psychologic, or somatic treatments. Patients with treatment-resistant depression have few remedies other than electroconvulsive therapy or transcranial magnetic stimulation. Recent research has highlighted the promising antidepressant effects of subanesthetic ketamine infusions. This journal course examines the efficacy of ketamine for treatment-resistant depression. Evidence from 10 systematic reviews and randomized controlled trials suggest that most of the researchers concluded ketamine significantly decreased depression severity ratings at short-term assessment intervals, whereas evidence examining the long-term effects is lacking. Ketamine infusion therapy was generally well tolerated, with minimal untoward effects. Large, randomized controlled trials are needed to discern the longer-term efficacy, tolerance, and dependence profiles of ketamine infusions. Optimal dosing schedules to best prolong the antidepressant effects of ketamine have yet to be determined.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
|---|---|
| Enthalten in: |
AANA journal - 87(2019), 5 vom: 26. Okt., Seite 411-419 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lent, Jennifer K [VerfasserIn] |
|---|
| Themen: |
690G0D6V8H |
|---|
| Anmerkungen: |
Date Completed 09.03.2020 Date Revised 09.03.2020 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM302195211 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302195211 | ||
| 003 | DE-627 | ||
| 005 | 20231225110217.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1007.xml |
| 035 | |a (DE-627)NLM302195211 | ||
| 035 | |a (NLM)31612847 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lent, Jennifer K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ketamine and Treatment-Resistant Depression |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2020 | ||
| 500 | |a Date Revised 09.03.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© by the American Association of Nurse Anesthetists. | ||
| 520 | |a Major depressive disorder affects tens of millions of people each year. One-third of those affected have depression that is resistant to conventional pharmacologic, psychologic, or somatic treatments. Patients with treatment-resistant depression have few remedies other than electroconvulsive therapy or transcranial magnetic stimulation. Recent research has highlighted the promising antidepressant effects of subanesthetic ketamine infusions. This journal course examines the efficacy of ketamine for treatment-resistant depression. Evidence from 10 systematic reviews and randomized controlled trials suggest that most of the researchers concluded ketamine significantly decreased depression severity ratings at short-term assessment intervals, whereas evidence examining the long-term effects is lacking. Ketamine infusion therapy was generally well tolerated, with minimal untoward effects. Large, randomized controlled trials are needed to discern the longer-term efficacy, tolerance, and dependence profiles of ketamine infusions. Optimal dosing schedules to best prolong the antidepressant effects of ketamine have yet to be determined | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Ketamine | |
| 650 | 4 | |a MADRS | |
| 650 | 4 | |a major depressive disorder | |
| 650 | 4 | |a refractory depression | |
| 650 | 4 | |a treatment-resistant depression | |
| 650 | 7 | |a Anesthetics, Dissociative |2 NLM | |
| 650 | 7 | |a Ketamine |2 NLM | |
| 650 | 7 | |a 690G0D6V8H |2 NLM | |
| 700 | 1 | |a Arredondo, Albert |e verfasserin |4 aut | |
| 700 | 1 | |a Pugh, Marilyn A |e verfasserin |4 aut | |
| 700 | 1 | |a Austin, Paul N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AANA journal |d 1974 |g 87(2019), 5 vom: 26. Okt., Seite 411-419 |w (DE-627)NLM000064939 |x 2162-5239 |7 nnns |
| 773 | 1 | 8 | |g volume:87 |g year:2019 |g number:5 |g day:26 |g month:10 |g pages:411-419 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 87 |j 2019 |e 5 |b 26 |c 10 |h 411-419 | ||